FGF23 and chronic kidney disease: Similar clinical data comes from a study of 17 adult patients with CKD and bacterial sepsis, who presented increased proteolysis of the FGF23 peptide at the peak of the bacterial infection, which was reduced after the resolution of the infection [22].